Policy & Ethics

Physicians often have to provide unwanted news; very few patients came into my office wanting and hoping for surgery.

It's difficult to predict what sort of nonsense is going to come out of San Francisco.

The Trump Administration issued two executive orders relating to biomedical science in recent days. The first involved the regulation of biotechnology products, and the second involved transparency in healthcare costs.

It's mildly amusing that ACSH is referred to as "industry-friendly." That term, which is applied to us by friend and foe alike, is based on a half-truth. And half-truths are the worst kind of "truths" because they're actually lies.

The state of Oklahoma is smelling blood in the water and it is going after blood money.

Public health is our passion at ACSH. We want to promote public health while simultaneously preserving individual liberty. That's been our goal since we were founded in 1978.

I'm often left shaking my head in amazement at the CDC, for both good and bad reasons.

We no longer can avoid the inevitable: We need to engage in an honest debate about how we pay for health care in the United States.

It is commonly believed by some that the cost of care in teaching hospitals, the sites where we train future physicians, is higher than that of community hospitals that do not have the additional burden of trainees.

We at ACSH don't like to brag (1). But I'll make an exception this time. Here's why.